EUVIMEDEUVIMED entdecken
Crossref

30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes

Lara I Calligaro, Gerald Liew, Yoon Hi Cho, Digby W Allen, Alison Pryke, Janine Cusumano, Albert Chan, Maria E Craig iD, Kim C Donaghue iD

Diabetes Care · 01.09.2026 · 49 (9) · 1613-1620

DOI: 10.2337/dc26-0388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 08.07.2026. Verfasst von Lara I Calligaro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To examine trends in microvascular complications in adolescents from 1990 to 2019. RESEARCH DESIGNS AND METHODS Retinopathy, albuminuria, and peripheral and autonomic nerve function (pupil size and heart rate variability [HRV]) were assessed in 2,761 adolescents aged 12–20 years (duration ≥5 years) over 5,487 visits. Generalized estimating equations were used to examine the association between decades T1 (1990–1999), T2 (2000–2009), and T3 (2010–2019), and modifiable risk factors, including HbA1c variability, were assessed by coefficient of variation (CV). RESULTS Retinopathy (T1 40%, T2 21%, T3 20%; P < 0.001) and early elevation of mean albumin-to-creatinine ratio (ACR) (T1 35%, T2 29%, T3 28%; P = 0.009) plateaued and peripheral nerve abnormality rates decreased (T2 35%, T3 28%; P = 0.007), while HRV abnormality (T2 37%, T3 38%; P = 0.884) and albuminuria (T1 6%, T2 4%, T3 4%; P = 0.164) were unchanged. Over time, multiple daily injection (MDI)/continuous subcutaneous insulin infusion (CSII) use increased, with a decrease in the proportion of adolescents achieving HbA1c <7.0% (T1 7.4%, T2 9.6%, T3 14.1%). In a multivariable model including HbA1c, HbA1c CV, diabetes duration, diastolic blood pressure, and insulin dose per kilogram body weight, retinopathy and early elevation of albumin excretion rate (AER) were associated with twice-daily insulin versus MDI/CSII (odds ratio 1.59 [95% CI 1.23–2.06; P < 0.001], 1.26 [1.06–1.48]; P = 0.007]). After adjusting for mean intrapersonal HbA1c, higher HbA1c CV was associated with early elevation of AER/ACR (1.27 [1.05–1.53; P = 0.015]), albuminuria (1.26 [1.04–1.52; P = 0.018]), and HRV abnormality (1.49 [1.08–2.05; P = 0.015]). CONCLUSIONS Diabetes complications decreased then plateaued over time. These findings support lower glycemic targets, CSII use, and targeting of modifiable risk factors and HbA1c CV to reduce complications risk in youth with type 1 diabetes. The role of hybrid closed-loop therapy should be evaluated in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HumansAdolescentMaleFemaleChildAlbuminuriaYoung AdultGlycated HemoglobinDiabetic RetinopathyInsulinHypoglycemic AgentsHeart Rate

Substanzen

Glycated HemoglobinInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, Australia.
  • Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Specialty of Child and Adolescent Health/Charles Perkins Centre Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Discipline of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Kensington, Australia.
  • School of Women's and Children's Health, University of New South Wales, Sydney, Australia.

ORCID-Profile: Maria E Craig, Kim C Donaghue

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Calligaro, L. I., Liew, G., Cho, Y. H., Allen, D. W., Pryke, A., Cusumano, J., Chan, A., Craig, M. E., & Donaghue, K. C. (2026). 30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes. Diabetes Care, 49(9), 1613-1620. https://doi.org/10.2337/dc26-0388

Vancouver

Calligaro LI, Liew G, Cho YH, Allen DW, Pryke A, Cusumano J, et al. 30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes. Diabetes Care. 2026;49(9):1613-1620. doi:10.2337/dc26-0388

BibTeX
@article{Calligaro2026,
  author = {Calligaro, Lara I and Liew, Gerald and Cho, Yoon Hi and Allen, Digby W and Pryke, Alison and Cusumano, Janine and Chan, Albert and Craig, Maria E and Donaghue, Kim C},
  title = {30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes},
  journal = {Diabetes Care},
  year = {2026},
  volume = {49},
  number = {9},
  pages = {1613--1620},
  doi = {10.2337/dc26-0388}
}
Kostenlos starten →